Emicizumab in Patients With Acquired Hemophilia A
Clinical trial NCT05345197 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05345197
- Sponsor
- University of Washington
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2026-07-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.